TrialInternational journal of rheumatic diseases2026

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Efficacy of Subcutaneous Firsekibart in Gout: A Phase Ib/II Clinical Trial.

Yu Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.